News
All News
Contributors
Money Matters
Media
Expert Interviews
Medical World News
Podcasts
Case Based Roundtable Series
Case of the Quarter
EyeView
Grand Rounds
Insights
Rapid Readout
Viewpoints
What’s Your WhEYE?
Conferences
Conference Coverage
Conference Listing
Events
Publications
Digital Edition
Europe Ophthalmology Times
Modern Retina
Supplements and Featured Publications
CME
Partners
Subscribe
Resources
Job Board
Sponsored
Choose Specialty
AMD
Biosimilars
COVID-19
Cataract
Cataract
Cataract Therapeutics
Clinical Diagnosis
Cornea
DME
Dry Eye
Dry Eye
Gene Therapy
Geographic Atrophy
Glaucoma
Glaucoma
Glaucoma
Glaucoma
IOL
IOL
Imaging
OCT
Ocular Allergy
Ocular Surface Disease
Optic Relief
Optometry
Pediatrics
Pharmacy
Practice Management
Practice Management
Presbyopia
Ptosis
Refractive
Refractive
Retina
Surgery
Technology
Therapeutics
Understanding Antibiotic Resistance
Workplace
Spotlight -
Retina
Choose Specialty
AMD
Biosimilars
COVID-19
Cataract
Cataract
Cataract Therapeutics
Clinical Diagnosis
Cornea
DME
Dry Eye
Dry Eye
Gene Therapy
Geographic Atrophy
Glaucoma
Glaucoma
Glaucoma
Glaucoma
IOL
IOL
Imaging
OCT
Ocular Allergy
Ocular Surface Disease
Optic Relief
Optometry
Pediatrics
Pharmacy
Practice Management
Practice Management
Presbyopia
Ptosis
Refractive
Refractive
Retina
Surgery
Technology
Therapeutics
Understanding Antibiotic Resistance
Workplace
Spotlight
News
Media
Conferences
Events
Publications
CME
Partners
Subscribe
Resources
Advertisement
Adam M. Katz, MD
home
/
authors
/
adam-m-katz-md
Katz is an ophthalmologist at Center for Advanced Eye Care in Vero Beach, FL.
Articles
New content coming soon.
Latest Updated Articles
Published: May 15th 2024
| Updated: May 20th 2024
Minimizing the carbon footprint of ophthalmic surgeries
Published: July 22nd 2024
| Updated: July 27th 2024
ASRS 2024: Safety and durability of voretigene neparvovec-rzyl for biallelic RPE65
Published: July 19th 2024
| Updated: July 27th 2024
ASRS 2024: Neurotech Pharmaceuticals update on the NT-501 device
Published: July 24th 2024
| Updated: July 27th 2024
Eyenovia, Inc. and Senju Pharmaceutical Co., Ltd. sign new collaboration agreement
Published: July 19th 2024
| Updated: July 27th 2024
ASRS 2024: Update on the phase 2 DAVIO 2 trial
Published: January 6th 2021
| Updated: July 27th 2024
Thinking and rethinking ophthalmology: Are you?